Non-Hodgkin's lymphoma in Pakistan : A clinicopathological profile of 175 patients

Journal of the Pakistan Medical Association

Volumn 49, Issue 1, 1999, Pages 11-15

  Aziz, Zeba ^a   Rehman, Amjad ^a   Akram, M ^a   Saeed, Asif ^a  

^a ALLAMA IQBAL MEDICAL COLLEGE   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CLASSIFICATION; COMPARATIVE STUDY; FEMALE; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; NONHODGKIN LYMPHOMA; PAKISTAN; PATHOLOGY; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASM STAGING; PAKISTAN; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE;

EID: 0032620004     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Weisenburger DD. Epidemiology of non-Hodgkin's lymphoma. Recent findings regarding an emerging epidemic. Ann. Oncol., 1994;15:19 (Suppl 1).
2. The National Cancer Data Base Report on Non-Hodgkin's Lymphoma: Cancer, 1997;80:2311-20.
3. Parkin DM (ed). Cancer occurrence in developing countries. IARC Scientific Publication No.75, Lyon International agency for research in cancer. Cancer, 1986;196-231.
4. Intragumtornchai T, Wannakrairoj P, Chaimongkol B, et al. Non-Hodgkin's lymphomas in Thailand. A retrospective pathologic and clinical analysis of 1391 cases. Cancer. 1996;78:1813-19.
5. Ji X, Li W. Malignant lymphoma in Beijing. J. Environ. Pathol. Toxicol. Oncol., 1992;11:327-9.
6. Chi JG, Shin SS, Ahn GH, et al. Malignant lymphomas in Korea. Jpn. J. Clin. Oncol., 1985;15:653.
7. Obafunwa JO, Akinsete I. Malignant lymphomas in Jos. Nigeria. A ten year study. Cent. Afr. J. Med, 1992;38:17-25.
8. Jussawalla DJ, Gangadharan P. Epidemiology of Cancer in the Indian subcontinent, series IV. Indian J. Cancer, 1974;11:3-11.
9. Azar HA. Cancer in Lebanon and the Near East. Cancer, 1962;15:66-78.
10. Ahmad M, Khan AH, Mansoor A. The pattern of malignant tumors in Northern Pakistan. AFIP monograph No. 1, Rawalpindi, Armed Forces Institute of Pathology, 1990.
11. Pakistan Medical Research Council. Report of multicentre study on malignant tumors. Islamabad, 1982, pp. 5-7.
12. Piankijagum A, Pacharee P, Wasi P. Malignant lymphomas in Thailand. An analysis of 1095 cases. J. Med. Assoc., Thai., 1980;63:181-91.
13. Abrar A. Sadaqat AG. Non-Hodgkin's lymphoma in South Punjab. Retrospective analysis of 148 patients. Pak. J. Med. Res., 1989;28:223-31.
14. Aboul Nasr AL, Tawfik HN, Abu El Einen M. Lymphoreticular tumors and leukemias in Egypt. J. Natl. Cancer, Inst., 1973;50:1619-21.
15. Garg A, Dawar R. Agarwal V, et al. Non-Hodgkin's lymphoma in Northern India. A retrospective analysis of 238 cases. Cancer. 1985;56:972-77.
16. David J, Straus MD, Daniel A, et al. The Non-Hodgkin's lymphomas. A retrospective clinical and pathologic analysis of 499 cases diagnosed between 1958 and 1969. Cancer, 1983;51:101-9.
17. Philip S, Elias A, Charrles A, et al. Non-Hodgkin's lymphomas in the Middle East, A study of 417 patients with emphasis on special features. Cancer. 1986;58:1162-66.
18. Kadin ME, Berard CW, Nanba K, et al. Lymphoproliferative diseases in Japan and Western countries. Hum. Pathol., 1983;14:745.
19. Gallagher CJ, Gregory WM, Jones AE. et al. Follicular lymphoma: Prognostic factors for response and survival. J. Clin. Oncol., 1986;4:1470-80.
20. Rosenberg SA, Berard CW, Brown BW, et al. National cancer institute sponsored study of classification of non-Hodgkin's lymphoma: summary and description of a working formulation for clinical usage. Cancer, 1982;49:2112-35.
21. Bosco J, Cherian R, Lin HP, et al. Leukemia and lymphoma in Malaysia. Leuk. Res. 1985;9:789.
22. Ho FCS, Todd D, Loke SI, et al. Clinico-pathological features of malignant lymphomas in 294 Hong Kong Chinese patients: Retrospective study covering an eigh-year period. Int J. Cancer. 1984;34:143.
23. Magrath IT. Malignant Non-hodgkin's lymphoma. In Pizzo PA. Poplack DG. (eds). Principles and practice of pediatric oncology. Philadelphia, JB Lippincolt, 1989, p. 415.
24. Richard I, Fisher MD, Ellen R, et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced Non-Hodgkin's lymphoma, N. Engl. J. Med., 1993;328:1002-6.
25. Gordon LI, Harrington D, Anderson J, et al. Comparison of a second generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse Non-Hodgkin's lymphoma. N. Engl. J. Med., 1992;327:1342-49.
26. International Non Hodgkin's Lymphomas Prognostic Factor Project A predictive model for aggressive Non-Hodgkin's lymphoma. N. Engl. J. Med., 1993;329:987-94.
27. Parkin DM, Sohier R, O'Connor GT. Geographical distribution of Burkitt's lymphoma. In: Lenior GM, O'OConor GT and Olweny CLM (eds). Burkitt's lymphoma. A human cancer model. Lyon: International agency for research on cancer. IARC, IARC Science Publication No.60, 1985, pp. 155-64.
28. Dalldorf G. Lymphomas in African children with different forms of environmental influences. JAMA., 1962;181:1026.
29. Klien G. The Epstien Barr Virus and neoplasia. N. Engl. J. Med., 1975;293:1353-57.
30. Vineis PD, Amore F. The role of occupational exposure and immunodeficiency in B cell malignancies. Working Group on Epidemiology of hematolymphopoetic malignancies in Italy. Epidemiology, 1992;3:266-70.
31. Chandra RK. Rouettes forming T cells and cell mediated immunity in malnutrition. Br. Med. J., 1974;2:608-9.